We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > patient

News List

Majority of patients with depression getting poor care pharmatimes
March 31, 2017
Seventy-five percent of people with major depression in Europe are not receiving adequate treatment, and yet it is the ...
Diurnal and Clinigen to introduce patient access programme for unlicensed products in Europe pharmaceutical-technology
March 20, 2017
UK-based pharmaceutical company Diurnal has collaborated with Clinigen's IDIS managed access unit to introduce a...
Toxicological risk evaluation of extractable and leachable from single use systems used to manufactu pharmaasia
March 14, 2017
Regulatory guidance states and industry best practices encourage drug safety specification, data to address potential issues not addressed during clinical studies.
First patient enrolled in Phase II study evaluating JZP-110 for excessive sleepiness in Parkinson's cphi-online
February 14, 2017
JZP-110 is a selective dopamine and norepinephrine reuptake inhibitor.
RedHill Biopharma Announces Enrollment of Last Patient in BEKINDA® Phase III Study for Acute Gastroe b3cnewswire
February 14, 2017
RedHill Biopharma Ltd. announced enrollment of the last patient in the Phase III study with BEKINDA® 24 mg for the treatment of acute gastroenteritis and gastritis (the GUARD study).

Previous page 1 2 3 4 5 Next page